Clinical Trials Browser

Phase 2 × Immunohistochemistry × Thoracic × Clear all

NCT00601848 2020-11-24

Photodynamic Therapy in Treating Patients With Resectable Non-Small Cell Lung Cancer That Has Spread to the Pleura

Phase 2 Terminated

9 enrolled 5 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis, Pleural Effusion, Malignant

NCT00729612 2018-04-02

Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer

Phase 2 Completed

63 enrolled 8 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00362882 2017-12-05

Docetaxel and Bortezomib in Treating Patients With Progressive or Recurrent Non-Small Cell Lung Cancer

Phase 2 Completed

81 enrolled 10 charts

Carcinoma, Non-Small-Cell Lung

NCT00499655 2017-03-29

Erlotinib Hydrochloride With or Without Celecoxib in Treating Patients With Stage IIIB-IV Non-Small Cell Lung Cancer

Phase 2 Completed

107 enrolled 10 charts

Carcinoma, Non-Small-Cell Lung

NCT00530634 2015-10-29

Surgery, Gemcitabine, Cisplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Non-Small Cell Lung Cancer

Phase 2 Terminated

3 enrolled 3 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00041028 2015-05-01

EF5 in Assessing Tumor Response to Anticancer Therapy in Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00801385 2009-08-25

Sorafenib and Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Has Not Responded to Chemotherapy

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms